Cognitive dysfunction and cancer: which consequences in terms of disease management?
about
Emerging pharmacotherapy for cancer patients with cognitive dysfunctionStem Cell Transplantation Reverses Chemotherapy-Induced Cognitive DysfunctionMemory and cancer: a review of the literatureStem cell therapies for the treatment of radiation-induced normal tissue side effects.Self-reported cognitive concerns and abilities: two sides of one coin?Evaluation of the impact of the cancer therapy everolimus on the central nervous system in miceNeuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.Self-reported memory problems in adult-onset cancer survivors: effects of cardiovascular disease and insomniaPAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell GrowthOptimism and Spontaneous Self-affirmation are Associated with Lower Likelihood of Cognitive Impairment and Greater Positive Affect among Cancer Survivors.Sex-specific effects of cytotoxic chemotherapy agents cyclophosphamide and mitomycin C on gene expression, oxidative DNA damage, and epigenetic alterations in the prefrontal cortex and hippocampus - an aging connectionOxidative stress and neurodegenerative disordersBroadening the cancer and cognition landscape: the role of self-regulatory challenges.Peripheral tumors alter neuroinflammatory responses to lipopolysaccharide in female rats.Autobiographical memory, self, and stress-related psychiatric disorders: which implications in cancer patients?Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.Ginger augmented chemotherapy: A novel multitarget nontoxic approach for cancer management.Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey.Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients.Feasibility and efficacy of speed-feedback therapy with a bicycle ergometer on cognitive function in elderly cancer patients in Japan.Fluvoxamine alleviates paclitaxel-induced neurotoxicity.Effects of Cyclophosphamide (CYP) and/or Doxorubicin (DOX) in a Murine Model of Post-Chemotherapy Cognitive Impairment.Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue.Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats.Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.Effects of acute administration of melatonin on attentional, executive, and working memory processes in rats.Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia.
P2860
Q27026729-059C6348-FBDB-46FC-91B4-CB89FF53A4C5Q27347898-37D2F284-E3CE-4DF5-8032-75136FD036B6Q33663544-2F70E004-943A-41B6-A842-271B9F6160C2Q33768112-3B99F161-23D8-480A-A628-5045EB927C53Q34288191-420C744B-CAE5-4452-8401-9D98FE403221Q34600979-88EEE374-B6B1-4703-93B3-5871692A0625Q34633028-0DCA4FEB-B466-42ED-9D23-2247272F84DFQ35738596-89348451-4BE8-4628-8EF2-3BBA71EC9877Q36310404-BC00B777-FE5C-400D-84C1-758BA6ADA517Q37033666-3044ABED-5670-47C1-85BF-9E83CD8A816CQ37049097-F3D87F08-6FB4-4749-A545-61A6A0B74BC3Q37421024-89976B9D-267F-4070-9CD4-1CDAC4EDED04Q37431860-00190AB8-6705-4C14-916D-55F847114CD0Q37667770-EB3451A1-5159-4393-A6F5-8F520D3239CBQ38103770-E1FBFDC8-FA90-492A-91BA-ACC51F5C7AF7Q38161296-D960B5B0-314E-4AEC-9131-B93CAA0FDD71Q38722201-30BE3DD1-7469-4932-B20C-072A4696A4E4Q41518631-7E9637FA-5821-4A33-AAC2-3B0F07765513Q45347505-9C6C1F7C-3673-4A71-AA52-965F0C0E715EQ45960920-B622A7ED-E0F0-42C1-A375-F987089F6DC2Q47120441-1E0CD47F-07C0-41FD-A317-39E84C8AE5D7Q47566624-F704ADEA-CCFD-4DA5-AD2B-0FDA2DBA5CC3Q47795655-C09ADEAF-7AE1-4553-A96D-35F22CF8C893Q47966922-C83601E2-3F45-43DB-88E4-784570B66805Q48334506-423BCA93-5457-435C-85DF-E7D25B2ED7AEQ48447955-34582570-CB37-4B8B-801C-EAB4261FDECEQ50576930-5D92CBFB-0DBF-4E4A-A76A-27DB2EAB69CEQ50914949-3D2BA626-8FB7-4735-ABB1-3893B13EB3CA
P2860
Cognitive dysfunction and cancer: which consequences in terms of disease management?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@en
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@nl
type
label
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@en
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@nl
prefLabel
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@en
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@nl
P2093
P2860
P356
P1433
P1476
Cognitive dysfunction and cancer: which consequences in terms of disease management?
@en
P2093
Bénédicte Giffard
Florence Joly
Olivier Rigal
Sabine Noal
P2860
P304
P356
10.1002/PON.1903
P577
2011-01-21T00:00:00Z